Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.19925 | 49 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.92415 | 40 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.18671 | 50 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.20002 | 52 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.14638 | 50 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.20882 | 47 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.18225 | 47 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.49039 | 58 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.55502 | 59 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.18347 | 50 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.13503 | 48 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.16786 | 50 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.16858 | 49 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.17398 | 49 |